New drug trial targets liver scarring in MASH patients
NCT ID NCT06903065
First seen Jun 27, 2026 · Last updated Jul 16, 2026 · Updated 2 times
Summary
This early-stage study tests a new medicine called RO7790121 in 50 adults with advanced liver scarring from MASH (a type of fatty liver disease). The main goal is to see if the drug is safe and how the body processes it. Researchers will also check if it can reduce liver stiffness and improve markers of liver damage.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MASH are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Adobe Clinical Research, LLC
Tucson, Arizona, 85712, United States
-
Bellaire Clinical Research, LLC
Bellaire, Texas, 77401, United States
-
Centro de Investigacion y Gastroenterologia
Mexico City, Mexico CITY (federal District), 06700, Mexico
-
DHR Health Institute for Research and Development
McAllen, Texas, 78504, United States
-
Delta Research Partners, LLC (Bastrop)
Bastrop, Louisiana, 71220, United States
-
FDI Clinicial Research - Mayaguez
Mayagez, 00680, Puerto Rico
-
Fundacion Santos Y De La Garza Evia IBP
San Pedro Garza García, Nuevo León, 66278, Mexico
-
Fundacion de Investigacion de Diego
San Juan, 00927, Puerto Rico
-
GI Alliance
Southlake, Texas, 76092, United States
-
Gastrointestinal Specialists of Georgia, PC
Marietta, Georgia, 30060, United States
-
Innovative Clinical Research
Clarksville, Tennessee, 37040, United States
-
Jubilee Clinical Research NV, LLC
Las Vegas, Nevada, 89106, United States
-
Pinnacle Clinical Research - Austin
Austin, Texas, 78757, United States
-
Pinnacle Clinical Research Georgetown
Georgetown, Texas, 78626, United States
-
Pinnacle Clinical Research, PLLC
San Antonio, Texas, 78229, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a once-daily pill help children with fatty liver disease?
- Fatty liver disease: a new biobank aims to unlock the secrets of a silent epidemic
- New MASH drug OPK-88006 enters early human testing
- New pill for fatty liver disease enters first human tests
- New gut implant aims to tackle diabetes and obesity without surgery
- New models aim to predict liver disease in HIV patients